Cornerstone Planning Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6K | Buy |
42
+8
| +24% | +$3.35K | ﹤0.01% | 446 |
|
|
2025
Q1 | $8.23K | Buy |
34
+11
| +48% | +$2.66K | ﹤0.01% | 620 |
|
|
2024
Q4 | $6.37K | Hold |
23
| – | – | ﹤0.01% | 530 |
|
|
2024
Q3 | $6.55K | Buy |
23
+10
| +77% | +$2.85K | ﹤0.01% | 511 |
|
|
2024
Q2 | $3.45K | Buy |
+13
| New | +$3.45K | ﹤0.01% | 650 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | -$191 | – | 1109 |
|
|
2023
Q4 | $191 | Hold |
1
| – | – | ﹤0.01% | 865 |
|
|
2023
Q3 | $177 | Buy |
+1
| New | +$177 | ﹤0.01% | 1040 |
|